Bladder cancer in Spain 2011: Population based study

Journal of Urology

Volumn 191, Issue 2, 2014, Pages 323-328

  Minana B ^a   Cozar J M ^a   Palou, J ^a   Unda Urzaiz, M ^a   Medina Lopez, R A ^a   Subirá Ríos, Jorge ^a   De La Rosa Kehrmann, F ^a   Chantada Abal, V ^a   Lozano, F ^a   Ribal, Maria J ^a   Rodriguez Fernandez E ^a   Castineiras Fernandez J ^a   Concepción Masip, Tomás ^a   Requena Tapia, M J ^a   Moreno Sierra, J ^a   Hevia, M ^a   Gomez Rodriguez A ^a   Martinez Ballesteros C ^a   Ramos, M ^a   Amón Sesmero, José H ^a   Piza Reus P ^a   Bohorquez Barrientos, A ^a   Rioja Sanz, Carlos ^a   Gomez Pascual, J Angel ^a   Hidalgo Zabala, E ^a   Parra Escobar, J L ^a   Serrano, O ^a   more..

^a NONE

Author keywords

incidence; neoplasm staging; Spain; urinary bladder neoplasms

Indexed keywords

ADULT; AGED; ARTICLE; BLADDER CANCER; CANCER RECURRENCE; CARCINOMA IN SITU; FEMALE; HEALTH CARE; HEMATURIA; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MEDICAL CARE; MIDDLE AGED; NON MUSCLE INVASIVE BLADDER CANCER; ORGANIZATIONAL STRUCTURE; POPULATION; PRIORITY JOURNAL; PUBLIC HOSPITAL; SPAIN; VERY ELDERLY; WORLD HEALTH ORGANIZATION; CANCER CHEMOTHERAPY; CANCER CLASSIFICATION; CANCER INCIDENCE; CANCER RADIOTHERAPY; CANCER SURGERY; HIGH RISK PATIENT; HUMAN TISSUE; PRIMARY TUMOR;

BACILLUS CALMETTE-GUÉRIN; BC; BCG; BLADDER CANCER; BMI; BODY MASS INDEX; CARCINOMA IN SITU; CIS; INCIDENCE; MITOMYCIN C; MMC; NEOPLASM STAGING; NMIBC; NONMUSCLE INVASIVE BLADDER CANCER; SPAIN; TRANSURETHRAL BLADDER TUMOR RESECTION; TURBT; URINARY BLADDER NEOPLASMS;

ADMINISTRATION, INTRAVESICAL; ADULT; AGED; AGED, 80 AND OVER; ANTIBIOTICS, ANTINEOPLASTIC; COMORBIDITY; FEMALE; HEMATURIA; HUMANS; INCIDENCE; MALE; MIDDLE AGED; MITOMYCIN; NEOPLASM INVASIVENESS; NEOPLASM STAGING; POPULATION SURVEILLANCE; SMOKING; SPAIN; URINARY BLADDER NEOPLASMS; YOUNG ADULT;

EID: 84891944738     PISSN: 00225347     EISSN: 15273792     Source Type: Journal    
DOI: 10.1016/j.juro.2013.08.049     Document Type: Article

References (29)

1. M. Babjuk, W. Oosterlinck, and R. Sylvester et al. Guidelines on TaT1 (Non-muscle invasive) Bladder Cancer 2008 European Association of Urology Arnhem, the Netherlands
2. M. Babjuk, W. Oosterlinck, and R. Sylvester et al. EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder, the 2011 update Actas Urol Esp 36 2012 389
3. J. Ferlay, E. Steliarova-Foucher, and J. Lortet-Tieulent et al. Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012 Eur J Cancer 49 2013 1374
4. L.A. Kiemeney, J.A. Witjes, and A.L. Verbeek et al. The clinical epidemiology of superficial bladder cancer. Dutch South-East Cooperative Urological Group Br J Cancer 67 1993 806
5. R. Lee, and M.J. Droller The natural history of bladder cancer. Implications for therapy Urol Clin North Am 27 2000 1
6. J. Leissner, R. Hohenfellner, and J.W. Thüroff et al. Lymphadenectomy in patients with transitional cell carcinoma of the urinary bladder; significance for staging and prognosis BJU Int 85 2000 817
7. Steliarova-Foucher E, O'Callaghan M, Ferlay J, et al. European Cancer Observatory: Cancer Incidence, Mortality, Prevalence and Survival in Europe. Version 1.0 (September 2012). European Network of Cancer Registries, International Agency for Research on Cancer. Available at http://eco.iarc.fr. Accessed May 13, 2013.
8. Instituto Nacional de Estadística, 2011. Madrid: INE. Available at www.ine.es/. Accessed June 6, 2012.
9. World Population Prospects 1990 1991 United Nations New York
10. Howlader N, Noone AM, Krapcho M, et al. SEER Cancer Statistics Review, 1975-2010, National Cancer Institute, Bethesda, Maryland. Available at http://seer.cancer.gov/csr/1975-2010. Accessed August 1, 2013.
11. M. García Gómez, R. Urbanos Garrido, and R. Castañeda López et al. Direct health care costs of lung and bladder cancer attributable to work. Spain, 2008 Rev Esp Salud Publica 86 2012 127
12. K. Noyes, E.A. Singer, and E.M. Messing Healthcare economics of bladder cancer: cost-enhancing and cost-reducing factors Curr Opin Urol 18 2008 533
13. J.M. Cózar, B. Miñana, and F. Gómez-Veiga et al. Prostate cancer incidence and newly diagnosed patient profile in Spain in 2010 BJU Int 110 2012 E701
14. A. Jemal, R. Siegel, and J. Xu et al. Cancer statistics, 2010 CA Cancer J Clin 60 2010 277
15. A. Stenzl, N.C. Cowan, and M. De Santis et al. Treatment of muscle-invasive and metastatic bladder cancer: update of the EAU guidelines Actas Urol Esp 36 2012 449
16. J. Ferlay, H.R. Shin, and F. Bray et al. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008 Int J Cancer 127 2010 2893
17. S. Holmäng, H. Hedelin, and C. Anderström et al. Prospective registration of all patients in a geographical region with newly diagnosed bladder carcinomas during a two-year period Scand J Urol Nephrol 34 2000 95
18. B.K. Bjerregaard, O. Raaschou-Nielsen, and M. Sørensen et al. Tobacco smoke and bladder cancer-in the European Prospective Investigation into Cancer and Nutrition Int J Cancer 119 2006 2412
19. D. Puente, P. Hartge, and E. Greiser et al. A pooled analysis of bladder cancer case-control studies evaluating smoking in men and women Cancer Causes Control 17 2006 71
20. K.B. Cummings, J.G. Barone, and W.S. Ward Diagnosis and staging of bladder cancer Urol Clin North Am 19 1992 455
21. H. Fajkovic, J.A. Halpern, and E.K. Cha et al. Impact of gender on bladder cancer incidence, staging, and prognosis World J Urol 29 2011 457
22. M.P. Herman, R.S. Svatek, and Y. Lotan et al. Urine-based biomarkers for the early detection and surveillance of non-muscle invasive bladder cancer Minerva Urol Nefrol 60 2008 217
23. F. Millan-Rodríguez, G. Chéchile-Toniolo, and J. Salvador-Bayarri et al. Upper urinary tract tumors after primary superficial bladder tumors: prognostic factors and risk groups J Urol 164 2000 1183
24. A.R. Schned, A.S. Andrew, and C.J. Marsit et al. Histological classification and stage of newly diagnosed bladder cancer in a population-based study from the Northeastern United States Scand J Urol Nephrol 42 2008 237
25. F. Millán-Rodríguez, G. Chéchile-Toniolo, and J. Salvador-Bayarri et al. Multivariate analysis of the prognostic factors of primary superficial bladder cancer J Urol 163 2000 73
26. B.W. van Rhijn, M. Burger, and Y. Lotan et al. Recurrence and progression of disease in non-muscle-invasive bladder cancer: from epidemiology to treatment strategy Eur Urol 56 2009 430
27. F.N. Joudi, B.J. Smith, and M.A. O'Donnell et al. Contemporary management of superficial bladder cancer in the United States: a pattern of care analysis Urology 62 2003 1083
28. J. Dobruch, and H. Herr Should all patients receive single chemotherapeutic agent instillation after bladder tumour resection? BJU Int 104 2009 170
29. K. Chamie, C.S. Saigal, and J. Lai et al. Compliance with guidelines for patients with bladder cancer: variation in the delivery of care Cancer 117 2011 5392